Abelcet and Furosemide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abelcet (amphotericin b) and Furosemide (furosemide). Common drug interactions include bradycardia among females and hyperbilirubinaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Abelcet and Furosemide. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Abelcet?

Abelcet has active ingredients of amphotericin b. eHealthMe is studying from 853 Abelcet users. Check the latest studies of Abelcet.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

34 people who take Abelcet and Furosemide together, and have interactions are studied.

Abelcet and Furosemide drug interactions.

What are the common drug interactions of Abelcet and Furosemide, by gender? *:

female:

Bradycardia (abnormally slow heart action)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Nodal rhythm (40-50 beats per minute)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Blood creatinine increased
Cardiac arrest
Cardiac tamponade (fluid accumulates in heart covering)
Chest pain
Deafness
Diarrhoea

male:

Hyperbilirubinaemia (excess of bilirubin in the blood)
Neutropenia (an abnormally low number of neutrophils)
Cardiac death
Cystitis haemorrhagic (blood in the urine and painful voiding)
Delayed engraftment
Hepatomegaly (abnormal enlargement of the liver)
Hospitalisation
Hyperkalaemia (damage to or disease of the kidney)
Hypotension (abnormally low blood pressure)
Mucosal inflammation (infection of mucous membrane)

What are the common drug interactions of Abelcet and Furosemide, by age (0-1 to 60+)? *:

0-1:

Bradycardia (abnormally slow heart action)
Electrocardiogram qt prolonged
Endocarditis (inflammation in heart muscle)
Organ failure
Renal failure acute (rapid kidney dysfunction)
Renal impairment (severely reduced kidney function)
Sepsis (a severe blood infection that can lead to organ failure and death)

2-9:

Hyperbilirubinaemia (excess of bilirubin in the blood)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

10-19:

n/a

20-29:

n/a

30-39:

Bradycardia (abnormally slow heart action)
Cardiac death
Hyperkalaemia (damage to or disease of the kidney)
Oxygen saturation decreased
Respiratory rate increased (excess breathing rate/min)
Ventricular fibrillation (abnormally irregular heart rhythm)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Pleural effusion (water on the lungs)
Pneumonia
Respiratory failure (inadequate gas exchange by the respiratory system)

40-49:

Blood creatinine increased
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
Cardiac tamponade (fluid accumulates in heart covering)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Chest pain
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Febrile neutropenia (fever with reduced white blood cells)
Herpes virus infection
Infusion related reaction

50-59:

Infusion related reaction
Blood bilirubin increased
Cardiac arrest
Cardiotoxicity (damage to the heart muscle)
Erythema (redness of the skin)
Hyperkalaemia (damage to or disease of the kidney)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Pulmonary toxicity (side effects on the lungs)
Rales (an abnormal respiratory sound characterized by fine crackles)
Respiratory distress (difficulty in breathing)

60+:

Hyperbilirubinaemia (excess of bilirubin in the blood)
Neutropenia (an abnormally low number of neutrophils)
Confusional state
Deafness
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Infection
Platelet count decreased
Post procedural complication
Pulmonary oedema (fluid accumulation in the lungs)
Respiratory distress (difficulty in breathing)

What are the existing conditions these people have? *

Pain: 6 people, 17.65%
Nausea (feeling of having an urge to vomit): 5 people, 14.71%
Fever: 5 people, 14.71%
Diarrhea: 5 people, 14.71%
Constipation: 5 people, 14.71%
Abdominal Pain: 5 people, 14.71%
Thrombocytopenia (decrease of platelets in blood): 4 people, 11.76%
Hypokalemia (low potassium): 4 people, 11.76%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 4 people, 11.76%
Enterococcal Infection: 4 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Abelcet and Furosemide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously